Horner syndrome is a rare condition classically presenting with partial ptosis (drooping or falling of upper eyelid), miosis (constricted pupil) and facial anhidrosis (loss of sweating) due to a disruption in the sympathetic nerve supply. It is primarily acquired following damage to the sympathetic nerve supply, but rare cases of congenital forms have been seen. Treatment is centered around identification and appropriate management of the underlying secondary cause.
The syndrome has several names such as Bernard-Horner syndrome (French-speaking countries), Horner syndrome (English speaking countries), oculosympathetic palsy and Von Passow syndrome (Horner syndrome in association with iris heterochromia).
The syndrome was first described by Francois Pourfour du Petit in 1727 when considering results from an animal experiment involving resection of intercostal nerves and subsequent changes seen in the ipsilateral eye and face. It was outlined more thoroughly by the French physiologist, Claude Bernard in 1852, followed by several physicians who offered different interpretations.
Understanding the sympathetic innervation of the eye is vital to understanding the features of this syndrome. The nerve supply is constituted by three different neurons, starting from the posterolateral hypothalamus and ending as the long ciliary nerves to supply the iris dilator and superior tarsal muscles (Muller muscle).
The first-order neurons originate from the hypothalamus and descend through the midbrain and pons uncrossed, terminating at the C8-T2 level of the spinal cord in the intermediolateral cell columns (ciliospinal center of Budge). Second-order preganglionic neurons exit at the T1 level of the spinal cord to enter the cervical sympathetic chain where the fibers ascend to synapse in the superior cervical ganglion at C3-C4 level.
Third-order, postganglionic fibers, branch off into the sudomotor and vasomotor fibers which follow the external carotid artery and innervate the sweat glands and blood vessels of the face. The remaining fibers ascend along the internal carotid artery in the carotid plexus to eventually enter the cavernous sinus where they join the abducens nerve (CN VI). The fibers then exit the cavernous sinus to enter the orbit via the superior orbital fissure along with the ophthalmic branch (V1) of the trigeminal nerve (CN V) as the long ciliary nerves.
Horner syndrome is primarily an acquired condition secondary to systemic/local diseases or iatrogenic causes but may be congenital, and in some rare cases, purely hereditary. Sympathetic fibers have an extensive course and can be interrupted during extracranial, intracranial, or intra-orbital traversal. Preganglionic Horner syndrome can be an ominous sign due to its association with pulmonary malignancies. Overall, the causes of Horner syndrome can be divided according to the anatomical location of disruption. 
First-order neurons are mostly affected by intracranial conditions and include the following:
Second-order neurons traverse the thoracic region and are affected by the following:
Third-order neurons are in close proximity to the internal carotid artery and cavernous sinus and are affected by the following:
Horner syndrome is uncommon, occurring with a frequency of approximately 1 per 6,000. It may occur at any age or with any ethnic group.
As previously described, Horner syndrome is a consequence of sympathetic disruption. The symptomology depends on the location of the lesion, and severity depends on the degree of denervation.
Superior tarsal muscle helps raise the upper eyelid and has a sympathetic nerve supply. Denervation of this muscle causes ptosis which is milder compared to oculomotor (CN III) palsy which supplies the levator palpebrae superioris. Superior tarsal muscle is responsible for keeping upper eyelid in a raised position after levator palpebrae superioris raises it. This explains the partial ptosis seen in Horner syndrome. The lower eyelid may be slightly elevated owing to denervation of lower lid muscle which is analogous to the superior tarsal muscle.
Sympathetic nervous supply is responsible for the dilation of the pupil (mydriasis). When disrupted, parasympathetic supply is uninhibited, and constriction of the pupil (miosis) ensues. The reaction of the pupils to light and accommodation is normal as those systems do not depend on sympathetic nerve supply.
Ipsilateral anhidrosis, another classic presentation, depends on the level of interruption of sympathetic supply. Anhidrosis with first-order neuron lesions affects the ipsilateral side of the body as the sympathetic supply from its central origin. The ipsilateral face is involved in lesions involving the second-order neurons. Postganglionic third-order neuron lesions occurring after the vasomotor and sudomotor fibers have branched off show very limited involvement of the face (area adjacent to ipsilateral brow).
Iris heterochromia (relevant deficiency of pigment in the iris on the affected side) is seen in children younger than 2 years and in the congenital form of Horner syndrome. 
Localization of the lesion in Horner syndrome is crucial in subsequent management. A detailed history and physical examination are, therefore, of vital importance. When evaluating, the following points need to be considered:
A detailed examination of the eyes is warranted and should include the following:
A detailed exam can reveal a round and constricted pupil. The affected pupil exhibits dilation lag (dilates more slowly), and the unequal pupils are appreciated more in darkness compared to light. The ciliospinal reflex may be absent.
Furthermore, partial ptosis, iris heterochromia, apparent enophthalmos, contralateral eyelid retraction, injected conjunctivae, and no change or transient decrease in intraocular pressure may be seen. 
It is important to perform a detailed systemic examination, paying specific attention to neurological, pulmonary, and cardiovascular systems and considering various differentials discussed later.
This is the most helpful testing modality for diagnostic localization. 
Topical cocaine test
Cocaine acts an indirect sympathomimetic inhibiting the reuptake of norepinephrine from the synaptic cleft. Cocaine solution (ranging from 2% to 10%) is instilled into both eyes. Both eyes are evaluated after at least 30 or more minutes for an optimal response. Denervation in the affected eye causes it to dilate poorly compared to the normal one. Anisocoria of 0.8 mm or more is considered diagnostic. The test does not help in identifying the level of lesion.
The test has other disadvantages such as comparatively high prices of the compound, time-consuming, test yielding ambiguous results, and the metabolites of cocaine can be detected in urine. 
Topical hydroxyamphetamine test
This test is particularly helpful in the localization of the lesion. Hydroxyamphetamine stimulates the release of stored norepinephrine from the postganglionic terminals into the synapse. Postganglionic third-order lesions can be differentiated from presynaptic second-order or first-order ones.
Two drops of 1% hydroxyamphetamine solution are instilled into both eyes. The affected eye (third-order lesion) will not dilate as well as the normal eye. While in the case of intact postganglionic fibers (first and second-order lesions), the affected pupil dilates to an equal or greater extent.
Disadvantages involving this test include it not being able to be performed on the same day as the cocaine test and false-negative results. 
Topical apraclonidine test
This test is considered the test of choice due to good sensitivity and overall practicality. Apraclonidine acts as a weak alpha1-agonist and strong alpha2-agonist. It is categorized as an ocular hypotensive agent. The upregulation of alpha1-receptors in Horner syndrome translates into an exaggerated response of the iris dilators (denervation supersensitivity) to an agonist agent like apraclonidine.
A 0.5-1% solution is instilled in both eyes. The affected eye will show mydriasis, while the normal eye is predominantly insensitive. Consequent instillation of the solution results in evident reversal of anisocoria (the affected pupil dilates and the normal pupil constricts). This is because of the stronger alpha 2 agonist activity of compared to the weaker alpha 1 agonist activity of apraclonidine.
Some disadvantages of this form of testing include false-negative results in acute cases, systemic side effects in the pediatric population, inability to localize lesion, and relatively long half-life of the drug.
Other agents have been proposed but fall short of clinical relevance due to several reasons.
Treatment options are based on the diagnosis and management of the underlying cause. Timely diagnosis is of critical importance followed by referral to an appropriate specialist. Healthcare professionals are advised to incorporate the importance of eye examinations into their acumen.
As previously described, pain accompanied with Horner syndrome points towards a more insidious underlying cause and should be evaluated thoroughly. Systemic symptoms such as weight loss and progressive fatigue can indicate an underlying malignancy. Furthermore, Horner syndrome can be an early manifestation of neuroblastoma in the pediatric population.
Carotid artery dissection can present with a unilateral headache and facial or neck pain. If suspected, urgent appropriate workup and treatment are warranted.
Raeder paratrigeminal syndrome also can present with headaches but is accompanied by trigeminal nerve (CN V) impairment.
Anisocoria and/or ptosis can be due to myriad diseases and conditions such as Holmes-Adie syndrome, neurosyphilis (Argyll Robertson pupil), third nerve palsy, or optic neuritis.
There are many causes of Horner syndrome and thus the condition is best managed by an interprofessional team that includes nurse practitioners. The key is to determine the location of the eye defect. Thus, it is important to perform a detailed systemic examination, paying specific attention to neurological, pulmonary, and cardiovascular systems and considering various differentials discussed later.
The outcomes depend on the cause.
|||Thompson HS, Johann Friedrich Horner (1831-1886). American journal of ophthalmology. 1986 Dec 15; [PubMed PMID: 3538884]|
|||Johann Friedrich Horner, (1831-1886) [PubMed PMID: 4890333]|
|||Mitchell SW,Morehouse GR,Keen WW, Gunshot wounds and other injuries of nerves. 1864. Clinical orthopaedics and related research. 2007 May; [PubMed PMID: 17473596]|
|||DURHAM DG, Congenital hereditary Horner's syndrome. A.M.A. archives of ophthalmology. 1958 Nov; [PubMed PMID: 13582337]|
|||Biousse V,Touboul PJ,D'Anglejan-Chatillon J,Lévy C,Schaison M,Bousser MG, Ophthalmologic manifestations of internal carotid artery dissection. American journal of ophthalmology. 1998 Oct; [PubMed PMID: 9780102]|
|||Reede DL,Garcon E,Smoker WR,Kardon R, Horner's syndrome: clinical and radiographic evaluation. Neuroimaging clinics of North America. 2008 May; [PubMed PMID: 18466837]|
|||Lyrer PA,Brandt T,Metso TM,Metso AJ,Kloss M,Debette S,Leys D,Caso V,Pezzini A,Bonati LH,Thijs V,Bersano A,Touzé E,Gensicke H,Martin JJ,Lichy C,Tatlisumak T,Engelter ST,Grond-Ginsbach C, Clinical import of Horner syndrome in internal carotid and vertebral artery dissection. Neurology. 2014 May 6; [PubMed PMID: 24727317]|
|||Jadon A, Horner's syndrome and weakness of upper limb after epidural anaesthesia for caesarean section. Indian journal of anaesthesia. 2014 Jul; [PubMed PMID: 25197119]|
|||Ying X,Dandan G,Bin C, Postoperative Horner's syndrome after video-assisted thyroidectomy: a report of two cases. World journal of surgical oncology. 2013 Dec 30; [PubMed PMID: 24378178]|
|||Foss-Skiftesvik J,Hougaard MG,Larsen VA,Hansen K, Clinical Reasoning: Partial Horner syndrome and upper right limb symptoms following chiropractic manipulation. Neurology. 2015 May 26; [PubMed PMID: 26009566]|
|||Sandoval MA,Cabungcal AC, Horner syndrome after radical neck surgery for anaplastic thyroid carcinoma. BMJ case reports. 2015 Apr 9; [PubMed PMID: 25858945]|
|||Smith SJ,Diehl N,Leavitt JA,Mohney BG, Incidence of pediatric Horner syndrome and the risk of neuroblastoma: a population-based study. Archives of ophthalmology (Chicago, Ill. : 1960). 2010 Mar; [PubMed PMID: 20212203]|
|||Guglielmi V,Visser J,Arnold M,Sarikaya H,van den Berg R,Nederkoorn PJ,Leys D,Calvet D,Kloss M,Pezzini A,Tatlisumak T,Schilling S,Debette S,Coutinho JM, Triple and quadruple cervical artery dissections: a systematic review of individual patient data. Journal of neurology. 2019 Jun [PubMed PMID: 30904955]|
|||González-Aguado R,Morales-Angulo C,Obeso-Agüera S,Longarela-Herrero Y,García-Zornoza R,Acle Cervera L, Horner's syndrome after neck surgery. Acta otorrinolaringologica espanola. 2012 Jul-Aug; [PubMed PMID: 22502736]|
|||Pirouzian A,Holz HA,Ip KC,Sudesh R, Acquired infantile Horner syndrome and spontaneous internal carotid artery dissection: a case report and review of literature. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2010 Apr; [PubMed PMID: 20451860]|
|||Allen AY,Meyer DR, Neck procedures resulting in Horner syndrome. Ophthalmic plastic and reconstructive surgery. 2009 Jan-Feb; [PubMed PMID: 19273916]|
|||Almog Y,Gepstein R,Kesler A, Diagnostic value of imaging in horner syndrome in adults. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2010 Mar; [PubMed PMID: 20182199]|
|||Smit DP, Pharmacologic testing in Horner's syndrome - a new paradigm. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 2010 Nov 9; [PubMed PMID: 21081027]|
|||Mughal M,Longmuir R, Current pharmacologic testing for Horner syndrome. Current neurology and neuroscience reports. 2009 Sep; [PubMed PMID: 19664368]|
|||Koc F,Kavuncu S,Kansu T,Acaroglu G,Firat E, The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis. The British journal of ophthalmology. 2005 Nov; [PubMed PMID: 16234449]|